The involvement of programmed cell death 5 (PDCD5) in the regulation of apoptosis in cerebral ischemia/reperfusion injury

CNS Neuroscience and Therapeutics

Volumn 19, Issue 8, 2013, Pages 566-576

  Chen, Chun Hua ^a   Jiang, Zhao ^a   Yan, Jun Hao ^a   Yang, Lei ^a   Wang, Ke ^a   Chen, Ying Yu ^b   Han, Jing Yan ^c   Zhang, John H ^d   Zhou, Chang Man ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c The Key Lab of TCM Information Engineering of State Administration of Traditional Chinese Medicine   (China)

^d LOMA LINDA UNIVERSITY   (United States)

Author keywords

Apoptosis; MCAO; PDCD5; SiRNA in vivo

Indexed keywords

CASPASE 3; CD34 ANTIGEN; EVANS BLUE; FLUORESCENT DYE; GREEN FLUORESCENT PROTEIN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; PROGRAMMED CELL DEATH 5; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; SHAM PROCEDURE; WESTERN BLOTTING;

APOPTOSIS; MCAO; PDCD5; SIRNA IN VIVO;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BRAIN ISCHEMIA; HUMANS; MALE; NEOPLASM PROTEINS; NEURONS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84880701915     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12114     Document Type: Article

References (35)

1. Lansberg MG, O'Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e601S-e636S.
2. Liu H, Wang Y, Zhang Y, et al. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 1999;254:203-210.
3. Li H, Wang Q, Gao F, et al. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Oncol Rep 2008;20:573-579.
4. Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-548.
5. Yang YH, Zhao M, Li WM, et al. Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis 2006;11:993-1001.
6. Xu XR, Huang J, Xu ZG, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 2001;98:15089-15094.
7. Ruan GR, Qin YZ, Chen SS, et al. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk Res 2006;30:1159-1165.
8. Wang Y, Li X, Wang L, et al. An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci 2004;117:1525-1532.
9. Chen Y, Sun R, Han W, et al. Nuclear translocation of PDCD5 (TFAR19): An early signal for apoptosis? FEBS Lett 2001;509:191-196.
10. Rui M, Chen Y, Zhang Y, Ma D. Transfer of anti-TFAR19 monoclonal antibody into HeLa cells by in situ electroporation can inhibit the apoptosis. Life Sci 2002;71:1771-1778.
11. Chen LN, Wang Y, Ma DL, Chen YY. Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression. Apoptosis 2006;11:101-111.
12. Xu L, Chen Y, Song Q, Xu D, Wang Y, Ma D. PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis. Neoplasia 2009;11:345-354.
13. Hu Q, Chen C, Khatibi NH, et al. Lentivirus-mediated transfer of MMP-9 shRNA provides neuroprotection following focal ischemic brain injury in rats. Brain Res 2011;1367:347-359.
14. Hu Q, Chen C, Yan J, et al. Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model. Exp Neurol 2009;216:35-46.
15. Li L, Khatibi NH, Hu Q, et al. Transmembrane protein 166 regulates autophagic and apoptotic activities following focal cerebral ischemic injury in rats. Exp Neurol 2012;234:181-190.
16. Chen C, Hu Q, Yan J, et al. Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis 2009;33:509-517.
17. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.
18. Kawamura S, Yasui N, Shirasawa M, Fukasawa H. Rat middle cerebral artery occlusion using an intraluminal thread technique. Acta Neurochir (Wien) 1991;109:126-132.
19. Yin W, Badr AE, Mychaskiw G, Zhang JH. Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. Brain Res 2002;926:165-171.
20. ® attenuates blood-brain barrier disruption after middle cerebral artery occlusion in rats. Exp Neurol 2012;237:453-463.
21. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995;26:627-634.
22. Gursoy-Ozdemir Y, Bolay H, Saribas O, Dalkara T. Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke 2000;31:1974-1980.
23. Xi G, Hua Y, Keep RF, Younger JG, Hoff JT. Brain edema after intracerebral hemorrhage: The effects of systemic complement depletion. Acta Neurochir Suppl 2002;81:253-256.
24. Park S, Sinko PJ. P-glycoprotein and multidrug resistance-associated proteins limit the brain uptake of saquinavir in mice. J Pharmacol Exp Ther 2005;312:1249-1256.
25. Li Y, Zhou C, Calvert JW, Colohan AR, Zhang JH. Multiple effects of hyperbaric oxygen on the expression of HIF-1 alpha and apoptotic genes in a global ischemia-hypotension rat model. Exp Neurol 2005;191:198-210.
26. Yin D, Zhou C, Kusaka I, et al. Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. J Cereb Blood Flow Metab 2003;23:855-864.
27. Ostrowski RP, Colohan AR, Zhang JH. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 2005;25:554-571.
28. Wang Y, Li D, Fan H, et al. Cellular uptake of exogenous human PDCD5 protein. J Biol Chem 2006;281:24803-24817.
29. Yin A, Jiang Y, Zhang X, Zhao J, Luo H. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo. Eur J Pharmacol 2010;649:120-126.
30. Chen C, Zhou H, Xu L, et al. Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo. Apoptosis 2010;15:805-813.
31. Gu L, Jiang Y, Wang Y, et al. TFAR19 gene changes the biophysical properties of murine erythroleukemia cells. Cell Biochem Biophys 2005;43:355-363.
32. Wang S, Zeng X, Liu Y, et al. Construction and characterization of a PDCD5 recombinant lentivirus vector and its expression in tumor cells. Oncol Rep 2012;28:91-98.
33. Rosse T, Olivier R, Monney L, et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 1998;391:496-499.
34. Zhuge C, Chang Y, Li Y, Chen Y, Lei J. PDCD5-regulated cell fate decision after ultraviolet-irradiation-induced DNA damage. Biophys J 2011;101:2582-2591.
35. Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol 2007;35:495-516.